Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: New Uses For Opdivo, Trodelvy; Nextstellis Introduces A Novel Estrogen

Apr 17 2021

• By Bridget Silverman

Keeping Track Feature image

Related Content

Accelerated Approval: US FDA Panel To Reconsider Six Indications For Checkpoint Inhibitors

Mar 12 2021

COVID Antibody Products May Get To Use Viral Load As Surrogate For Mutant-Targeted Versions

Feb 18 2021

Regeneron And Lilly Are Back With Better COVID-19 Antibody Data – But Still Face Medical Skepticism

Feb 09 2021

Related Companies

Mayne Pharma USA

Mithra Pharmaceuticals SA

Bristol Myers Squibb Company

Seagen Inc.

Roche Holding AG

Eli Lilly and Company

Genentech, Inc.

Additional Topics

United States Drug Review Drug Approval Standards Approvals Regulation US FDA Performance Tracker BioPharmaceutical Cancer Gynecology & Urology Infectious Diseases Inflammation

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.